Menu
Recruiting NCT07599241

Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues

No phase Interventional Subclinical hypothyroïdism Non-Alcoholic Fatty Liver Disease Primary Open Angle Glaucoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: physical activity, usual care.
Who it may be relevant to
Registry conditions: Subclinical hypothyroïdism, Non-Alcoholic Fatty Liver Disease, Primary Open Angle Glaucoma. Basic parameters: 65 years — 75 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated

Detailed description

hypthyroidism elder females (n=40) with glaucoma and fatty liver issues will randomly divided into group number 1 (n=20) that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month or group number II (n=20) that will receive levothyroxine only

Interventions

  • Behavioral physical activity
    hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month
  • Other usual care
    hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine only

Primary outcome measures

  • intraocular pressure [Time frame: 6 months]
Secondary outcome measures (12)
  • body mass index [Time frame: 6 months]
  • waist circumfrence [Time frame: 6 months]
  • systolic blood pressure [Time frame: 6 months]
  • diastolic blood pressure [Time frame: 6 months]
  • glaucoma assocaited life quality survey [Time frame: 6 months]
  • triglyceridss [Time frame: 6 months]
  • high density lipoproteines [Time frame: 6 months]
  • alanine transamianses [Time frame: 6 months]
  • aspartate trasnamiansses [Time frame: 6 months]
  • physical conclusion of short form survey [Time frame: 6 months]
  • Mental conclusion of short form survey [Time frame: 6 months]
  • thyroid stimualting horomone [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • subclinical hypothrodism (significant form)
  • primary opened angle gaulcoma in both eyes with ocular hypertension in both eyes )(high-tension typed glaucoma)
  • fatty liver (non alcholic type)
  • elder females

Exclusion criteria

  • respiratory issues
  • cardiac issues
  • renal issues

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Dokki

Identifiers

NCT: NCT07599241 · IRB000-14233-75

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗